Social business spinouts: what are they and what is the current state…
There are many variations of a “social” business — where do they originate, how do you define each category and does it make sense to separate them at all?
Only through regional collaboration can the UK build a science superpower
If we want to build strength in places and tap into talent across the UK, we must create the conditions for success, argues Midlands Mindforge CEO Lisa Smith.
Spinouts from the perspective of the academic
The debate around equity stakes in UK spinouts often holds up the US as a perfect model to follow — but does the data show any actual differences between the two and what does that mean for academics?
Horizon Europe and the UK: is there a way forward?
The UK negotiated associate membership to Horizon Europe in its Withdrawal Agreement from the EU — two years later, it's unclear if it'll ever happen.
How to crack the nut of turning science into jobs: an Australian…
Campus Plus CEO Nick McNaughton looks at overseas programmes for early-stage innovation to understand how Australia could improve its own offering.
What next for healthcare CVC in 2023?
What's going to happen to healthcare startup funding this year? Will the IPO market recover? And what kinds of technologies are on the up? We asked some leading CVCs for their view.
Has Corporate Venture Capital unleashed its full potential yet?
Guest comment by Stefan Gabriel, Hitachi Ventures
CVC in the Time of Coronavirus: Shinichiro Hori, YJ Capital
Despite uncertainty, Yahoo Japan’s corporate venturing vehicle will continue its efforts in innovation and technology in the Japanese ecosystem through collaborations with startups.
CVC in the Time of Coronavirus: Blake Luse, Ferguson Ventures
Ferguson's investment arm is in weekly contact with portfolio companies and expects digitisation to be more widely adopted in the construction industry as work practices change.